Sonova's financial performance has taken a hit, with its half-year core profit falling short of market expectations. The Swiss hearing aid manufacturer attributed this shortfall to unfavorable currency exchange rates. Despite Sonova's robust full-year outlook for 14-18% growth in normalized core earnings, the impact of adverse currency conditions is expected to be more severe than initially anticipated, with a potential 13-14% reduction in results. This is a significant shift from the earlier forecast of a 5-6% impact. The company's quarterly results under the new management team, which is navigating a challenging landscape of a slower hearing aid market, intensifying competition, and tariff-related uncertainties, have also been affected. The U.S. market, which accounts for a substantial portion of Sonova's sales, is particularly vulnerable to the weakened dollar. This situation underscores the complex interplay between currency fluctuations and global business operations, leaving Sonova to adapt its strategies to mitigate the impact on its financial performance.
